Adisseo(600299)
Search documents
安迪苏股价跌5.01%,摩根基金旗下1只基金重仓,持有1.54万股浮亏损失8160.41元
Xin Lang Cai Jing· 2025-09-01 05:22
Group 1 - The core point of the news is that Andy Su's stock price dropped by 5.01% to 10.05 CNY per share, with a trading volume of 165 million CNY and a turnover rate of 0.60%, resulting in a total market capitalization of 26.953 billion CNY [1] - Andy Su, established on May 31, 1999, and listed on April 20, 2000, is based in Beijing and specializes in the research, production, and sales of animal nutrition additives. The revenue composition of its main business includes 76.07% from functional products and 23.93% from specialty products [1] Group 2 - From the perspective of major fund holdings, Morgan Fund has a significant position in Andy Su, with the Morgan Quantitative Multi-Factor Mixed Fund (005120) holding 15,400 shares, accounting for 0.96% of the fund's net value, ranking as the seventh largest holding. The estimated floating loss today is approximately 8,160.41 CNY [2] - The Morgan Quantitative Multi-Factor Mixed Fund (005120) was established on January 19, 2018, with a latest scale of 15.5269 million CNY. Year-to-date returns are 23.1%, ranking 3,438 out of 8,254 in its category; the one-year return is 48.11%, ranking 2,732 out of 8,037; and since inception, the return is 46.29% [2] - The fund manager, He Zhihao, has been in position for 4 years and 210 days, managing total assets of 15.43 billion CNY, with the best fund return during his tenure being 52.51% and the worst being -34.95% [2]
安迪苏2025年中报简析:营收净利润同比双双增长,公司应收账款体量较大
Zheng Quan Zhi Xing· 2025-08-30 23:26
Core Viewpoint - The recent financial report of Andisu (600299) shows a significant increase in revenue and net profit for the first half of 2025, indicating a positive growth trajectory despite some challenges in quarterly performance [1][2]. Financial Performance - The total revenue for the first half of 2025 reached 8.512 billion yuan, a year-on-year increase of 17.23% - The net profit attributable to shareholders was 740 million yuan, up 21.82% year-on-year - In Q2 2025, revenue was 4.213 billion yuan, reflecting an 11.89% increase year-on-year, while net profit decreased by 16.72% to 275 million yuan - The gross margin was 28.41%, down 9.41% year-on-year, while the net margin improved to 8.71%, an increase of 4.12% year-on-year - Total sales, management, and financial expenses amounted to 1.195 billion yuan, accounting for 14.03% of revenue, a decrease of 8.77% year-on-year [1]. Cash Flow and Receivables - The cash flow per share was 0.54 yuan, up 17.82% year-on-year - The accounts receivable were notably high, with accounts receivable to net profit ratio reaching 172.91%, indicating potential liquidity concerns [1][2]. Investment Returns - The company's return on invested capital (ROIC) for the previous year was 7.28%, which is considered average - The net profit margin was 7.76%, suggesting that the added value of products or services is also average - Historical data shows a median ROIC of 8.03% over the past decade, with a significant drop to 0.68% in 2023, indicating inconsistent investment returns [2]. Business Model and Strategy - The company's performance is primarily driven by marketing efforts, necessitating a thorough examination of the underlying drivers [2]. - Andisu has a history of mergers and acquisitions to expand its business, with significant milestones including joining the Bluestar Group in 2006 and multiple overseas acquisitions in recent years - The company aims to continue its acquisition strategy to enhance its product line and strengthen its dual-pillar development strategy [4]. Product Development - The company is focusing on the development of its single-cell protein product, "Faikang," which is positioned as a sustainable alternative to animal protein - The Chongqing factory is the first in the world to utilize disruptive fermentation technology for large-scale production, with ongoing development and government support - The factory has begun stable operations since Q2 2024, with significant orders fulfilled in early 2025, indicating progress in market expansion [4].
安迪苏:8月29日召开董事会会议
Mei Ri Jing Ji Xin Wen· 2025-08-29 18:36
每经AI快讯,安迪苏(SH 600299,收盘价:10.58元)8月30日发布公告称,公司第九届第八次董事会 会议于2025年8月29日以通讯表决的方式召开。会议审议了《2025年半年度报告及其摘要》等文件。 (记者 张喜威) 2024年1至12月份,安迪苏的营业收入构成为:营养及健康行业占比100.0%。 每经头条(nbdtoutiao)——近120个品牌、1600辆车逐鹿西南!下半年国内首个A级车展开幕:新能 源"第三极"将改写车市格局 ...
安迪苏: 安迪苏第九届董事会第八次会议决议公告
Zheng Quan Zhi Xing· 2025-08-29 10:25
蓝星安迪苏股份有限公司(以下简称"公司")第九届董事会第八次会议于 事会会议通知和材料分别于 2025 年 8 月 19 日、2025 年 8 月 26 日以电子邮件方 式发出。会议应参加表决董事 9 人,实际参加表决董事 9 人。本次会议符合《中 华人民共和国公司法》和《蓝星安迪苏股份有限公司章程》的有关规定。本次会 议由公司董事长郝志刚先生召集,公司部分高管列席会议。 第九届董事会第八次会议 决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 证券代码:600299 证券简称:安迪苏 公告编号:2025-037 蓝星安迪苏股份有限公司 参加会议的董事表决通过以下议案: 《 2025 年 半 年 度 报 告 及 其 摘 要 》 内 容 详 见 上 海 证 券 交 易 所 网 站 : www.sse.com.cn;《2025 年半年度报告摘要》详见《中国证券报》和《证券 日报》。 审计、风险及合规委员会审议通过该议案。 会议以 9 票同意,0 票反对,0 票弃权的表决结果审议通过了议案。 的议案 《中化集团财务有限责任公 ...
安迪苏: 安迪苏第九届监事会第六次会议决议公告
Zheng Quan Zhi Xing· 2025-08-29 10:25
证券代码:600299 证券简称:安迪苏 公告编号:2025-038 公司《2025 年半年度报告及其摘要》的编制和审议程序符合法律、法规、 《公司章程》、公司内部管理制度的各项规定; 公司《2025 年半年度报告及其摘要》的内容真实、准确、完整,不存在虚假 记载、误导性陈述或重大遗漏; 蓝星安迪苏股份有限公司 第九届监事会第六次会议 决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 蓝星安迪苏股份有限公司(简称"安迪苏"或"公司")第九届监事会第六 次会议于 2025 年 8 月 29 日以通讯表决的方式召开。监事会会议通知和材料及更 新后的监事会会议通知和材料分别于 2025 年 8 月 19 日、8 月 26 日以电子邮件方 式发出。会议应参加表决监事 3 人,实际参加表决监事 3 人。其中监事王岩先生 因工作安排未能亲自参会,委托监事路玮先生代为参加会议并行使表决权。本次 会议符合《中华人民共和国公司法》和《蓝星安迪苏股份有限公司章程》(以下 简称"《公司章程》")的有关规定。监事会主席王岩先生委托路玮先生召集 ...
安迪苏: 蓝星安迪苏股份有限公司审计、风险与合规委员会实施细则
Zheng Quan Zhi Xing· 2025-08-29 10:25
Core Points - The establishment of the Audit, Risk, and Compliance Committee aims to enhance the decision-making function of the board and ensure effective supervision of the management team [1][2] - The committee is responsible for overseeing both internal and external audits, compliance management, risk identification, prevention, and management [2][3] - The committee consists of at least three directors who are not senior management, with a majority being independent directors [2][3] Group 1: Committee Composition and Responsibilities - The committee must ensure members have sufficient time and expertise to fulfill their duties effectively [2] - The committee is tasked with supervising and evaluating external and internal audit work, reviewing financial information, and ensuring the effectiveness of internal controls [3][4] - The committee is required to provide necessary working conditions and support from the management team [2][3] Group 2: Decision-Making and Reporting - The committee must meet at least quarterly and can hold temporary meetings as needed [12][16] - Decisions made by the committee require a majority vote and must be reported to the board for further consideration [23][24] - The committee is responsible for reporting any significant issues related to compliance or internal controls to the board and relevant authorities [9][15] Group 3: Compliance and Risk Management - The committee oversees compliance with financial and non-financial regulations, ensuring adherence to company policies and legal requirements [10][11] - It is responsible for evaluating the company's risk management processes and ensuring that significant risks are identified and managed appropriately [21][22] - The committee must review and supervise the implementation of compliance risk assessment plans and address any complaints received [11][10]
安迪苏: 蓝星安迪苏股份有限公司章程
Zheng Quan Zhi Xing· 2025-08-29 10:25
蓝星安迪苏股份有限公司 章程 Bluestar Adisseo Company 蓝星安迪苏股份有限公司 章程 (2025年8月修订) 蓝星安迪苏股份有限公司 章程 目 录 蓝星安迪苏股份有限公司 章程 第一章 总则 公司是经国家经济贸易委员会批准,以发起方式设立;在北京市工商行政管 理局注册登记,取得营业执照。统一社会信用代码为 911100007109244940。 英文全称:Bluestar Adisseo Company 蓝星安迪苏股份有限公司 章程 理人员具有法律约束力的文件。依据本章程,股东可以起诉股东,股东可以 起诉公司董事、高级管理人员,股东可以起诉公司,公司可以起诉股东、董 事和高级管理人员。 第二章 经营宗旨和范围 。 第一条 为维护公司、股东、职工和债权人的合法权益,规范公司的组织和行为,根据《中 华人民共和国公司法》(以下简称"《公司法》")《中华人民共和国证券法》(以 下简称"《证券法》")和其他有关规定,制定本章程。 第二条 公司系依照《公司法》和其他有关规定成立的股份有限公司(以下简称"公司") 第三条 公司于 2000 年 2 月 25 日经中国证券监督管理委员会(以下简称"中国 ...
安迪苏: 蓝星安迪苏股份有限公司股东会议事规则
Zheng Quan Zhi Xing· 2025-08-29 10:25
蓝星安迪苏股份有限公司 股东会议事规则 蓝星安迪苏股份有限公司 股东会议事规则 蓝星安迪苏股份有限公司 股东会议事规则 第一章 总则 第一条 为规范公司行为,保证股东会依法行使职权,根据《中华人民共 和国公司法》(以下简称《公司法》)《中华人民共和国证券法》 《上海证券交易所股票上市规则》和《上市公司股东会规则》等有 关法律、行政法规和《蓝星安迪苏股份有限公司章程》 ( 以下简称 《公司章程》)的规定,制定本规则。 第二条 公司应当严格按照法律、行政法规、本规则及《公司章程》的相 关规定召开股东会,保证股东能够依法行使权利。 公司董事会应当切实履行职责,认真、按时组织股东会。公司全 体董事应当勤勉尽责,确保股东会正常召开和依法行使职权。 第三条 股东会应当在《公司法》和《公司章程》规定的范围内行使职权。 第四条 股东会分为年度股东会和临时股东会。年度股东会每年召开一次, 应当于上一会计年度结束后的6个月内举行。临时股东会不定期召 开,出现以下情形时,临时股东会应当在2个月内召开: (一)董事人数不足《公司法》规定人数或者《公司章程》所定 人数的 2/3 时; (二)公司未弥补的亏损达实收股本总额的 1/3 时 ...
安迪苏: 蓝星安迪苏股份有限公司董事会议事规则
Zheng Quan Zhi Xing· 2025-08-29 10:25
Core Points - The document outlines the rules governing the board of directors of Bluestar Adisseo Co., Ltd, aimed at improving corporate governance and decision-making efficiency [1][2][3] Group 1: Purpose and Authority - The rules are established to enhance the corporate governance structure and ensure scientific decision-making by the board [1] - The board has the authority to convene shareholder meetings, execute resolutions, and determine the company's operational plans and investments [2][3] Group 2: Board Responsibilities - The board is responsible for formulating annual financial plans, profit distribution schemes, and capital changes [2][3] - It also decides on significant acquisitions, mergers, and changes in company structure [2][3] Group 3: Meeting Procedures - The board must hold at least two regular meetings each year, with the chairman responsible for convening these meetings [6][7] - Proposals for meetings must be prepared in consultation with board members and submitted to the chairman for approval [6][7] Group 4: Voting and Decision-Making - Decisions require a majority vote from attending directors, with specific rules for related party transactions and financial assistance [14][15] - The board must ensure that decisions are made within the authority granted by the shareholders and the company's articles of association [15][16] Group 5: Documentation and Record-Keeping - The board secretary is responsible for maintaining meeting records, including attendance, proposals, and voting results [26][27] - Meeting records must be signed by attending directors, and any dissenting opinions should be documented [28][29]
安迪苏: 安迪苏关于取消监事会暨修订《公司章程》的公告
Zheng Quan Zhi Xing· 2025-08-29 10:24
证券代码:600299 证券简称:安迪苏 公告编号:2025-040 蓝星安迪苏股份有限公司 关于取消监事会暨修订《公司章程》的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 根据《公司法》等相关法律法规和规范性文件的规定及变化,结合公司的实 际情况,拟对《公司章程》部分条款进行修订,具体情况如下: | 序号 | 修订前 | 修订后 | | --- | --- | --- | | | 第一条 第一条 | | | | 为维护公司、股东和债权人的合法权 | 为维护公司、股东、职工和债权人的合法权益, | | | 华人民共和国公司法》 | | | | (以下简称《公 | 国公司法》(以下简称"《公司法》")《中 | | | 司法》)《中华人民共和国证券法》 | 华人民共和国证券法》 | | | | (以下简称"《证券法》 | | | | ") | | | 和其他有关规定,制订本章程。 | 和其他有关规定,制定本章程。 | | 序号 | 修订前 | 修订后 | | | 第二条 | 第二条 | | | 公司系依照《公司法》和其他有 ...